Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Rheumatoid Arthritis

Free Subscription Articles published in Rheumatol Int Retrieve available abstracts of 157 articles: HTML format

Single Articles

November 2023
1. BEKARYSSOVA D, Yessirkepov M, Mahmudov K
   Structure, demography, and medico-social characteristics of articular syndrome in rheumatic diseases: a retrospective monocentric analysis of 2019-2021 data.
   Rheumatol Int. 2023;43:2057-2064.
   PubMed     Abstract available
   
   
   
2. MAYER M, Martinic M, Reihl-Crnogaj M, Anic B, et al
   The risk of developing non-Hodgkin lymphoma and the mortality rate in primary Sjogren's syndrome: a single-centre, retrospective cohort study.
   Rheumatol Int. 2023;43:2031-2036.
   PubMed     Abstract available
   
   
   October 2023
3. VAN SLINGERLAND K, de Jong PHP, Dolhain RJEM, Pasma A, et al
   The effect of a goal-setting strategy with integrated feedback on goal attainment in inflammatory arthritis patients: a mixed method study.
   Rheumatol Int. 2023;43:1897-1904.
   PubMed     Abstract available
   
   
   September 2023
4. SULLI A, Clini P, Bruzzone G, Signori A, et al
   An engineered glove to follow finger function in rheumatoid arthritis: an observational prospective study.
   Rheumatol Int. 2023 Sep 13. doi: 10.1007/s00296-023-05444.
   PubMed     Abstract available
   
   
   
5. AMEZCUA-GUERRA LM, Carbonell-Bobadilla N, Soto-Fajardo C, Vargas A, et al
   Influence of anti-carbamylated protein antibodies on disease activity and joint erosions in seronegative and seropositive rheumatoid arthritis.
   Rheumatol Int. 2023 Sep 11. doi: 10.1007/s00296-023-05445.
   PubMed     Abstract available
   
   
   August 2023
6. BHAT SS, Ahmed S, Reji R, Mehta P, et al
   Efficacy and safety of curcumin in maintaining remission during disease-modifying antirheumatic drug withdrawal in rheumatoid arthritis at 52 weeks: a phase III double-blind, randomized placebo-controlled trial.
   Rheumatol Int. 2023 Aug 31. doi: 10.1007/s00296-023-05417.
   PubMed     Abstract available
   
   
   
7. AL-MAINI M, Maindarkar M, Kitas GD, Khanna NN, et al
   Artificial intelligence-based preventive, personalized and precision medicine for cardiovascular disease/stroke risk assessment in rheumatoid arthritis patients: a narrative review.
   Rheumatol Int. 2023 Aug 30. doi: 10.1007/s00296-023-05415.
   PubMed     Abstract available
   
   
   
8. MATHIEU S, Lambert C, Fayet F, Couderc M, et al
   Comparison of the cardiovascular risk profile of rheumatoid arthritis versus hand osteoarthritis patients.
   Rheumatol Int. 2023 Aug 11. doi: 10.1007/s00296-023-05405.
   PubMed     Abstract available
   
   
   July 2023
9. SUARDI I, Posio C, Luconi E, Boracchi P, et al
   Disease activity and disease-related factors are drivers of patient global assessment in rheumatoid arthritis: a real-life cross-sectional study.
   Rheumatol Int. 2023 Jul 16. doi: 10.1007/s00296-023-05383.
   PubMed     Abstract available
   
   
   
10. RAAD T, Griffin A, George ES, Larkin L, et al
    Experience and perceptions among rheumatoid arthritis patients following a telehealth-delivered dietary intervention: a qualitative study.
    Rheumatol Int. 2023 Jul 7. doi: 10.1007/s00296-023-05382.
    PubMed     Abstract available
    
    
    
11. ATHANASSIOU P, Psaltis D, Georgiadis A, Katsifis G, et al
    Real-world effectiveness of golimumab in adult patients with rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis and an inadequate response to initial TNFi therapy in Greece: the GO-BEYOND prospective, observational study.
    Rheumatol Int. 2023 Jul 5. doi: 10.1007/s00296-023-05376.
    PubMed     Abstract available
    
    
    
12. GASTELUM-STROZZI A, Flores-Alvarado DE, Pascual-Ramos V, Alvarez-Hernandez E, et al
    The COVID-19 epidemic curve and vaccine acceptance among patients with rheumatic diseases: an ecological study.
    Rheumatol Int. 2023;43:1253-1264.
    PubMed     Abstract available
    
    
    
13. FELIS-GIEMZA A, Chmurzynska K, Kolodziejczyk B, Gazda A, et al
    Revising diagnosis of juvenile idiopathic arthritis in adults: a single-center retrospective study.
    Rheumatol Int. 2023;43:1307-1311.
    PubMed     Abstract available
    
    
    
14. CHATTERJEE R, Balakrishnan A, Kharbanda R, Rathore U, et al
    Renal involvement in Sjogren's syndrome: predictors and impact on patient outcomes.
    Rheumatol Int. 2023;43:1297-1306.
    PubMed     Abstract available
    
    
    June 2023
15. WROBEL A, Baranska I, Szklarczyk J, Majda A, et al
    Relationship between perceived stress, stress coping strategies, and clinical status in patients with rheumatoid arthritis.
    Rheumatol Int. 2023 Jun 18. doi: 10.1007/s00296-023-05367.
    PubMed     Abstract available
    
    
    
16. VICTORIA MA, Lucio VR, Cristina HD
    Patient self-reported instruments for assessing symptoms in rheumatoid arthritis.
    Rheumatol Int. 2023 Jun 15. doi: 10.1007/s00296-023-05355.
    PubMed     Abstract available
    
    
    
17. GARCIA-SALINAS R, Sanchez-Prado E, Mareco J, Ronald P, et al
    Difficult to treat rheumatoid arthritis in a comprehensive evaluation program: frequency according to different objective evaluations.
    Rheumatol Int. 2023 Jun 3. doi: 10.1007/s00296-023-05349.
    PubMed     Abstract available
    
    
    
18. ERMEIDIS C, Dimitroulas T, Pourzitaki C, Voulgari PV, et al
    Perceived treatment satisfaction in patients with systemic rheumatic diseases treated with biologic therapies: results of a self-reported survey.
    Rheumatol Int. 2023;43:1151-1159.
    PubMed     Abstract available
    
    
    
19. URHAN E, Urhan AC, Dogan HO, Sahin A, et al
    Assessment of semaphorin 3A and semaphorin 7A levels in primary Sjogren's syndrome.
    Rheumatol Int. 2023;43:1087-1092.
    PubMed     Abstract available
    
    
    May 2023
20. O'BRIEN CM, Kitas GD, Rayner F, Isaacs JD, et al
    Number of days required to measure sedentary time and physical activity using accelerometery in rheumatoid arthritis: a reliability study.
    Rheumatol Int. 2023 May 25. doi: 10.1007/s00296-023-05342.
    PubMed     Abstract available
    
    
    
21. VENETSANOPOULOU AI, Alamanos Y, Voulgari PV, Drosos AA, et al
    Decline in the incidence of rheumatoid arthritis in north-western Greece in 1980-2019.
    Rheumatol Int. 2023 May 13. doi: 10.1007/s00296-023-05325.
    PubMed    
    
    
    April 2023
22. VAN DEN HOEK J, Sobejana M, van Nes F, Metsios G, et al
    Patient perspective on exercise intervention in rheumatoid arthritis with high risk of cardiovascular disease: a pilot qualitative study.
    Rheumatol Int. 2023 Apr 24. doi: 10.1007/s00296-023-05312.
    PubMed     Abstract available
    
    
    
23. AUSSERWINKLER M, Neumann HJ, Wernly B
    Rheumatoid arthritis and cardiovascular risk: keep it simple and compassionate.
    Rheumatol Int. 2023 Apr 24. doi: 10.1007/s00296-023-05333.
    PubMed    
    
    
    
24. NEYCHEVA S, Naseva E, Batalov Z, Karalilova R, et al
    Adherence to biological therapies in patients with rheumatoid arthritis: a retrospective cohort study.
    Rheumatol Int. 2023 Apr 19. doi: 10.1007/s00296-023-05327.
    PubMed     Abstract available
    
    
    
25. KODURI GM, Podlasek A, Pattapola S, Zhang J, et al
    Four-factor risk score for the prediction of interstitial lung disease in rheumatoid arthritis.
    Rheumatol Int. 2023 Apr 18. doi: 10.1007/s00296-023-05313.
    PubMed     Abstract available
    
    
    
26. SEPPEN BF, Wiegel J, Nurmohamed MT, Bos WH, et al
    Facilitators and barriers to adhere to monitoring disease activity with ePROs: a focus group study in patients with inflammatory arthritis.
    Rheumatol Int. 2023;43:677-685.
    PubMed     Abstract available
    
    
    
27. WILK M, Pripp AH, Korkosz M, Haugeberg G, et al
    Exploring pain catastrophizing and its associations with low disease activity in rheumatic inflammatory disorders.
    Rheumatol Int. 2023;43:687-694.
    PubMed     Abstract available
    
    
    
28. OTON T, Carmona L, Andreu JL
    What do patients on methotrexate need and expect at the clinic? An online patient survey.
    Rheumatol Int. 2023;43:735-741.
    PubMed     Abstract available
    
    
    
29. MUEHLENSIEPEN F, May S, Hadaschik K, Vuillerme N, et al
    Digitally supported shared decision-making and treat-to-target in rheumatology: a qualitative study embedded in a multicenter randomized controlled trial.
    Rheumatol Int. 2023;43:695-703.
    PubMed     Abstract available
    
    
    
30. TANAKA Y, Barrett C, Hirano Y, Ikeda K, et al
    Management of chronic rheumatic diseases in women 18-45 years of age in Asia Pacific: insights from patient and clinician surveys.
    Rheumatol Int. 2023;43:721-733.
    PubMed     Abstract available
    
    
    
31. LI Y, Berianu F, Brumble L, Calamia KT, et al
    Synovitis due to Histoplasma capsulatum: a case series and literature review.
    Rheumatol Int. 2023;43:763-769.
    PubMed     Abstract available
    
    
    
32. OZSOY Z, Ozdemir A, Ekici M, Bilgin E, et al
    Do the drug doses of conventional synthetic DMARDs used for the treatment of biologic/targeted-synthetic DMARDs naive rheumatoid arthritis patients affect QuantiFERON-TB Gold Plus test results?
    Rheumatol Int. 2023 Apr 1. doi: 10.1007/s00296-023-05320.
    PubMed     Abstract available
    
    
    March 2023
33. VENETSANOPOULOU AI, Kalpourtzi N, Alamanos Y, Gavana M, et al
    Prevalence of rheumatoid arthritis in Greece: results from the national health examination survey EMENO.
    Rheumatol Int. 2023 Mar 31. doi: 10.1007/s00296-023-05316.
    PubMed     Abstract available
    
    
    
34. DHIR V, Prasad CB, Kumar S, Kaul KK, et al
    Long-term persistence of oral methotrexate and associated factors in rheumatoid arthritis: a retrospective cohort study.
    Rheumatol Int. 2023 Mar 18. doi: 10.1007/s00296-023-05305.
    PubMed     Abstract available
    
    
    
35. LOSINSKA K, Korkosz M, Pripp AH, Haugeberg G, et al
    Real-world experience of rituximab biosimilar GP2013 in rheumatoid arthritis patients naive to or switched from reference rituximab.
    Rheumatol Int. 2023 Mar 16. doi: 10.1007/s00296-023-05307.
    PubMed     Abstract available
    
    
    
36. WROBEL A, Szklarczyk J, Baranska I, Majda A, et al
    Association between levels of serotonin, melatonin, cortisol and the clinical condition of patients with rheumatoid arthritis.
    Rheumatol Int. 2023 Mar 13. doi: 10.1007/s00296-023-05296.
    PubMed     Abstract available
    
    
    
37. PARPERIS K, Achilleos S, Costi E, Vardas M, et al
    Autoimmune rheumatic diseases associated with granulomatous mastitis.
    Rheumatol Int. 2023;43:399-407.
    PubMed     Abstract available
    
    
    
38. FRADE-SOSA B, Azuaga AB, Ruiz-Esquide V, Gomez-Puerta JA, et al
    Complete disappearance of pulmonary rheumatoid nodules after long term rituximab treatment: case report.
    Rheumatol Int. 2023;43:533-536.
    PubMed     Abstract available
    
    
    
39. CAPKIN E, Yazici A, Karkucak M, Durmaz Y, et al
    Evaluation of hepatitis serology and frequency of viral reactivation in patients with inflammatory arthritis receiving biologic agents: a multicenter observational study.
    Rheumatol Int. 2023;43:523-531.
    PubMed     Abstract available
    
    
    February 2023
40. CHARLES-SCHOEMAN C, Wang J, Shahbazian A, Wilhalme H, et al
    Power doppler ultrasound signal predicts abnormal HDL function in patients with rheumatoid arthritis.
    Rheumatol Int. 2023 Feb 24. doi: 10.1007/s00296-023-05285.
    PubMed     Abstract available
    
    
    
41. KOSTER F, Bakx PLH, Kok MR, Barreto DL, et al
    Multimorbidity status and annual healthcare expenditures of rheumatoid arthritis patients: a Dutch hospital-centered versus population-based comparison.
    Rheumatol Int. 2023 Feb 10. doi: 10.1007/s00296-023-05282.
    PubMed     Abstract available
    
    
    
42. PARASCHOU V, Partalidou S, Siolos P, Papadopoulou Z, et al
    Prevalence of hearing loss in patients with Sjogren syndrome: a systematic review and meta-analysis.
    Rheumatol Int. 2023;43:233-244.
    PubMed     Abstract available
    
    
    
43. YOLCU G, Abacar KY, Kenis-Coskun O, Nevsun-Inanc G, et al
    Comparison of cutaneous silent period parameters in patients with primary Sjogren's syndrome with the healthy population and determination of its relationship with clinical parameters.
    Rheumatol Int. 2023;43:355-362.
    PubMed     Abstract available
    
    
    January 2023
44. WIEGEL J, Seppen BF, Nurmohamed MT, Ter Wee MM, et al
    Predictors for response to electronic patient-reported outcomes in routine care in patients with rheumatoid arthritis: a retrospective cohort study.
    Rheumatol Int. 2023 Jan 30:1-7. doi: 10.1007/s00296-023-05278.
    PubMed     Abstract available
    
    
    
45. ELFVING P, Kononoff A, Huhtakangas J, Kautiainen H, et al
    Incidence of seropositive rheumatoid arthritis in population-based studies in Northern Savo, Finland, during 1980-2020.
    Rheumatol Int. 2023 Jan 11:1-8. doi: 10.1007/s00296-022-05268.
    PubMed     Abstract available
    
    
    
46. GHEITA TA, Raafat HA, El-Bakry SA, Elsaman A, et al
    Rheumatoid arthritis study of the Egyptian College of Rheumatology (ECR): nationwide presentation and worldwide stance.
    Rheumatol Int. 2023 Jan 8. doi: 10.1007/s00296-022-05258.
    PubMed     Abstract available
    
    
    
47. BALAKRISHNAN A, Majumder S, Guleria S, Lawrence A, et al
    Macrophage migration inhibitory factor (MIF) and IgA anti CD74 antibodies in Indian patients with enthesitis-related arthritis category of Juvenile idiopathic arthritis.
    Rheumatol Int. 2023;43:157-162.
    PubMed     Abstract available
    
    
    December 2022
48. KOCYIGIT BF, Sagtaganov Z, Yessirkepov M, Akyol A, et al
    Assessment of complementary and alternative medicine methods in the management of ankylosing spondylitis, rheumatoid arthritis, and fibromyalgia syndrome.
    Rheumatol Int. 2022 Dec 30:1-9. doi: 10.1007/s00296-022-05267.
    PubMed     Abstract available
    
    
    
49. SANAL-TOPRAK C, Unal-Ulutatar C, Duruoz E, Oz N, et al
    The validity and reliability of the Turkish version of the Arthritis Impact Measurement Scale 2-Short Form (AIMS2-SF) for rheumatoid arthritis.
    Rheumatol Int. 2022 Dec 11. doi: 10.1007/s00296-022-05257.
    PubMed     Abstract available
    
    
    
50. VIDEM V, Houge IS, Hoff M
    Persons with rheumatoid arthritis have higher barriers to physical activity than controls: a cross-sectional study using the Facilitators and Barriers to Physical Activity Questionnaire (FasBarPAQ).
    Rheumatol Int. 2022 Dec 7. doi: 10.1007/s00296-022-05252.
    PubMed     Abstract available
    
    
    
51. FEDKOV D, Berghofen A, Weiss C, Peine C, et al
    Efficacy and safety of a mobile app intervention in patients with inflammatory arthritis: a prospective pilot study.
    Rheumatol Int. 2022;42:2177-2190.
    PubMed     Abstract available
    
    
    
52. CHEN J, He Q, Jiang B, Song W, et al
    Research on primary Sjogren's syndrome in 2004-2021: a Web of Science-based cross-sectional bibliometric analysis.
    Rheumatol Int. 2022;42:2221-2229.
    PubMed     Abstract available
    
    
    November 2022
53. ZOUBI T, Gordon H
    Systematic review of associations between concomitant rheumatoid arthritis and peripheral arterial disease, health-related quality of life and functional capacity.
    Rheumatol Int. 2022 Nov 30. doi: 10.1007/s00296-022-05245.
    PubMed     Abstract available
    
    
    
54. SIEMPIS T, Tsakiris C, Anastasia Z, Alexiou GA, et al
    Radiological assessment and surgical management of cervical spine involvement in patients with rheumatoid arthritis.
    Rheumatol Int. 2022 Nov 15. pii: 10.1007/s00296-022-05239.
    PubMed     Abstract available
    
    
    
55. OUARDI NE, Maghraoui AE, Djossou HJ, Taoubane L, et al
    Discontinuation of biologic therapy in patients with rheumatoid arthritis and ankylosing spondylitis: analysis from multicenter cohort study.
    Rheumatol Int. 2022 Nov 5. pii: 10.1007/s00296-022-05237.
    PubMed     Abstract available
    
    
    
56. NUNE A, Barman B, Sapkota HR, Ish P, et al
    Nanotechnology applications in rheumatology.
    Rheumatol Int. 2022;42:1883-1891.
    PubMed     Abstract available
    
    
    
57. GASTEIGER C, Scholz U, Petrie KJ, Dalbeth N, et al
    A bio-what? Medical companions' perceptions towards biosimilars and information needs in rheumatology.
    Rheumatol Int. 2022;42:1993-2002.
    PubMed     Abstract available
    
    
    October 2022
58. BLANKEN AB, Raadsen R, Agca R, van Sijl AM, et al
    Effect of anti-inflammatory therapy on vascular biomarkers for subclinical cardiovascular disease in rheumatoid arthritis patients.
    Rheumatol Int. 2022 Oct 21. pii: 10.1007/s00296-022-05226.
    PubMed     Abstract available
    
    
    
59. MEDRADO LN, Mendonca MLM, Budib MB, Oliveira-Junior SA, et al
    Effectiveness of aquatic exercise in the treatment of inflammatory arthritis: systematic review.
    Rheumatol Int. 2022;42:1681-1691.
    PubMed     Abstract available
    
    
    
60. ILGEN U, Karadag O, Emmungil H, Kucuksahin O, et al
    Tuberculin skin test before biologic and targeted therapies: does the same rule apply for all?
    Rheumatol Int. 2022;42:1797-1806.
    PubMed     Abstract available
    
    
    September 2022
61. REN J, Ding Y, Zhao J, Sun Y, et al
    Impact of cigarette smoking on rheumatoid arthritis-associated lung diseases: a retrospective case control study on clinical and radiological features and prognosis.
    Rheumatol Int. 2022 Sep 27. pii: 10.1007/s00296-022-05219.
    PubMed     Abstract available
    
    
    
62. KOSTER F, Lopes Barreto D, Nair SC, Kok MR, et al
    Defining the care delivery value chain and mapping the patient journey in rheumatoid arthritis.
    Rheumatol Int. 2022 Sep 23. pii: 10.1007/s00296-022-05215.
    PubMed     Abstract available
    
    
    
63. HUANG G, Wu L, Mei Z, Yao D, et al
    Rheumatoid meningitis without a history of rheumatoid arthritis: a case report and literature review.
    Rheumatol Int. 2022 Sep 20. pii: 10.1007/s00296-022-05209.
    PubMed     Abstract available
    
    
    
64. ATALAR E, Yurdakul FG, Gok K, Guler T, et al
    Motor neuron disease in a patient with overlap syndrome (rheumatoid arthritis; systemic lupus erythematosus, Sjogren's syndrome).
    Rheumatol Int. 2022 Sep 18. pii: 10.1007/s00296-022-05207.
    PubMed     Abstract available
    
    
    
65. SWIECKA M, Paluch L, Pietruski P, Maslinska M, et al
    Shear wave elastography as a potential additional diagnostic tool in primary Sjogren's syndrome: an observational study.
    Rheumatol Int. 2022;42:1579-1587.
    PubMed     Abstract available
    
    
    
66. LENDREM DW, Tarn JR, Collins A, Wason J, et al
    Why stratification is important in primary Sjogren's syndrome.
    Rheumatol Int. 2022;42:1661-1662.
    PubMed    
    
    
    August 2022
67. JAIN A, Joseph S, James J, James TS, et al
    Delay in diagnosis of rheumatoid arthritis: reasons and trends over a decade.
    Rheumatol Int. 2022 Aug 23. pii: 10.1007/s00296-022-05187.
    PubMed     Abstract available
    
    
    
68. PARASKEVI VV, Aliki VI, Antigone P, Zoi T, et al
    Orbital myositis in systemic lupus erythematosus: a case-based review.
    Rheumatol Int. 2022;42:1453-1460.
    PubMed     Abstract available
    
    
    
69. SILVA EV, Almeida LY, Bortoletto KC, Quero IB, et al
    Focal lymphocytic sialadenitis and ectopic germinal centers in oral reactive lesions and primary Sjogren's syndrome: a comparative study.
    Rheumatol Int. 2022;42:1411-1421.
    PubMed     Abstract available
    
    
    
70. AL-EZZI M, Tappuni AR, Khan KS
    The impact of Sjgren's syndrome on the quality of sexual life of female patients in the UK: a controlled analysis.
    Rheumatol Int. 2022;42:1423-1429.
    PubMed     Abstract available
    
    
    July 2022
71. KOUGKAS N, Dara A, Pagkopoulou E, Dimitriadou A, et al
    Methotrexate induced neurotoxicity in a patient with rheumatoid arthritis on rituximab therapy: a case-based review.
    Rheumatol Int. 2022 Jul 18. pii: 10.1007/s00296-022-05166.
    PubMed     Abstract available
    
    
    
72. HAN P, Sun C, Zhang Y, Yan J, et al
    Sjogren's syndrome with adult-onset Still's disease: an overlap syndrome?
    Rheumatol Int. 2022;42:1281-1285.
    PubMed     Abstract available
    
    
    June 2022
73. BOYADZHIEVA V, Tachkov K, Stoilov N, Mitov K, et al
    Quality of life and disease activity of patients with rheumatoid arthritis on tofacitinib and biologic disease-modifying antirheumatic drug therapies.
    Rheumatol Int. 2022 Jun 27. pii: 10.1007/s00296-022-05163.
    PubMed     Abstract available
    
    
    
74. INGRAM T, Sengupta R, Standage M, Barnett R, et al
    Correlates of physical activity in adults with spondyloarthritis and rheumatoid arthritis: a systematic review.
    Rheumatol Int. 2022 Jun 8. pii: 10.1007/s00296-022-05142.
    PubMed     Abstract available
    
    
    May 2022
75. HOQUE A, Steultjens M, Dickson DM, Hendry GJ, et al
    Patients' and clinicians' perspectives on the clinical utility of the Rheumatoid Arthritis Foot Disease Activity Index.
    Rheumatol Int. 2022 May 27. pii: 10.1007/s00296-022-05147.
    PubMed     Abstract available
    
    
    
76. POPOVA V, Geneva-Popova M, Kraev K, Batalov A, et al
    Assessment of TNF-alpha expression in unstable atherosclerotic plaques, serum IL-6 and TNF-alpha levels in patients with acute coronary syndrome and rheumatoid arthritis.
    Rheumatol Int. 2022 May 26. pii: 10.1007/s00296-022-05113.
    PubMed     Abstract available
    
    
    
77. ZEKIC T, Benic MS, Radic M
    Treatment of rheumatoid arthritis with conventional, targeted and biological disease-modifying antirheumatic drugs in the setting of liver injury and non-alcoholic fatty liver disease.
    Rheumatol Int. 2022 May 23. pii: 10.1007/s00296-022-05143.
    PubMed     Abstract available
    
    
    April 2022
78. KARABULUT Y, Gezer HH, Esen S, Esen I, et al
    Tofacitinib monotherapy and erectile dysfunction in rheumatoid arthritis: a pilot observational study.
    Rheumatol Int. 2022 Apr 25. pii: 10.1007/s00296-022-05132.
    PubMed     Abstract available
    
    
    
79. PAPPAS DA, Brittle C, Concoff A, Holman AJ, et al
    Perspectives on applying immuno-autonomics to rheumatoid arthritis: results from an online rheumatologist survey.
    Rheumatol Int. 2022 Apr 21. pii: 10.1007/s00296-022-05122.
    PubMed     Abstract available
    
    
    
80. FEUCHTENBERGER M, Kovacs MS, Eder A, Nigg A, et al
    Methotrexate significantly reduces the humoral vaccination response against SARS-CoV-2 in older but not younger patients with rheumatoid arthritis.
    Rheumatol Int. 2022 Apr 16. pii: 10.1007/s00296-022-05123.
    PubMed     Abstract available
    
    
    
81. YOSHII I, Sawada N, Chijiwa T
    Clinical characteristics and variants that predict prognosis of difficult-to-treat rheumatoid arthritis.
    Rheumatol Int. 2022 Apr 11. pii: 10.1007/s00296-022-05124.
    PubMed     Abstract available
    
    
    
82. RODERE M, Pereira B, Soubrier M, Fayet F, et al
    Development and validation of a self-administered questionnaire measuring essential knowledge in patients with rheumatoid arthritis.
    Rheumatol Int. 2022 Apr 7. pii: 10.1007/s00296-022-05090.
    PubMed     Abstract available
    
    
    
83. YOSHIMURA M, Fujieda Y, Sugawara M, Kono M, et al
    Disease activity as a risk factor for venous thromboembolism in rheumatoid arthritis analysed using time-averaged DAS28CRP: a nested case-control study.
    Rheumatol Int. 2022 Apr 6. pii: 10.1007/s00296-022-05121.
    PubMed     Abstract available
    
    
    
84. JEON YH, Lim DH, Choi SW, Choi SJ, et al
    A flare of Still's disease following COVID-19 vaccination in a 34-year-old patient.
    Rheumatol Int. 2022;42:743-748.
    PubMed     Abstract available
    
    
    
85. ZHANG X, Yang Q, Yu H, Yin F, et al
    Bibliometric analysis of the global literature productivity of adult-onset Still's disease (2011-2020).
    Rheumatol Int. 2022;42:707-716.
    PubMed     Abstract available
    
    
    March 2022
86. SKACELOVA M, Nekvindova L, Mann H, Zavada J, et al
    The beneficial effect of csDMARDs co-medication on drug persistence of first-line TNF inhibitor in rheumatoid arthritis patients: data from Czech ATTRA registry.
    Rheumatol Int. 2022 Mar 26. pii: 10.1007/s00296-021-05072.
    PubMed     Abstract available
    
    
    
87. NAKAYAMA Y, Watanabe R, Murakami K, Murata K, et al
    Differential efficacy of TNF inhibitors with or without the immunoglobulin fragment crystallizable (Fc) portion in rheumatoid arthritis: the ANSWER cohort study.
    Rheumatol Int. 2022 Mar 10. pii: 10.1007/s00296-021-05086.
    PubMed     Abstract available
    
    
    
88. KABEERDOSS J, Sandhya P, Kurien BT, Scofield RH, et al
    In vitro effects of curcumin on proinflammatory cytokines and expression of their genes in minor salivary gland tissue of patients with Sjogren's syndrome.
    Rheumatol Int. 2022;42:545-551.
    PubMed     Abstract available
    
    
    February 2022
89. SKRZYPKOWSKA M, Stasiak M, Sakowska J, Chmiel J, et al
    Cytokines and chemokines multiplex analysis in patients with low disease activity rheumatoid arthritis.
    Rheumatol Int. 2022 Feb 18. pii: 10.1007/s00296-022-05103.
    PubMed     Abstract available
    
    
    
90. SWAIN N, Tripathy A, Padhan P, Raghav SK, et al
    Toll-like receptor-7 activation in CD8+ T cells modulates inflammatory mediators in patients with rheumatoid arthritis.
    Rheumatol Int. 2022 Feb 10. pii: 10.1007/s00296-021-05050.
    PubMed     Abstract available
    
    
    
91. QIN L, Zhang Y, Yang X, Luo Q, et al
    Cardiac involvement in primary Sjgren's syndrome.
    Rheumatol Int. 2022;42:179-189.
    PubMed     Abstract available
    
    
    January 2022
92. WILK M, Losinska K, Pripp AH, Korkosz M, et al
    Pain catastrophizing in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: biopsychosocial perspective and impact on health-related quality of life.
    Rheumatol Int. 2022 Jan 31. pii: 10.1007/s00296-021-05070.
    PubMed     Abstract available
    
    
    
93. PSALTIS D, Settas L, Georgiadis A, Koukli E, et al
    The effects of golimumab on patient centric outcomes amongst rheumatoid arthritis patients in Greece. The GO-Q study.
    Rheumatol Int. 2022 Jan 29. pii: 10.1007/s00296-021-05073.
    PubMed     Abstract available
    
    
    
94. HASAN AA, Reimann F, Veeger NJGM, Bergstra SA, et al
    Optical imaging compared to clinical examination in 484 rheumatoid arthritis patients: the Leeuwarden Handscan Registry.
    Rheumatol Int. 2022 Jan 27. pii: 10.1007/s00296-021-05060.
    PubMed     Abstract available
    
    
    
95. KOSTURKOVA MB, Mihaylova GM, Shivacheva TK, Radanova MA, et al
    Association of C1q gene cluster variants with rheumatoid arthritis: a pilot study.
    Rheumatol Int. 2022 Jan 13. pii: 10.1007/s00296-022-05089.
    PubMed     Abstract available
    
    
    
96. KONSTANTONIS G, Singh KV, Sfikakis PP, Jamthikar AD, et al
    Cardiovascular disease detection using machine learning and carotid/femoral arterial imaging frameworks in rheumatoid arthritis patients.
    Rheumatol Int. 2022 Jan 11. pii: 10.1007/s00296-021-05062.
    PubMed     Abstract available
    
    
    
97. VIDEM V, Hoff M, Liff MH
    Use of the Behavioral Regulation in Exercise Questionnaire-2 to assess motivation for physical activity in persons with rheumatoid arthritis: an observational study.
    Rheumatol Int. 2022 Jan 9. pii: 10.1007/s00296-021-05079.
    PubMed     Abstract available
    
    
    
98. LAROCHE M, Degboe Y, Constantin A
    Sjogren's syndrome associated with erosive rheumatoid arthritis alters its prognosis and long-term therapeutic response: a case-control study.
    Rheumatol Int. 2022 Jan 9. pii: 10.1007/s00296-021-05074.
    PubMed     Abstract available
    
    
    
99. TAYLAN A
    Rituximab therapy in pericarditis associated with rheumatoid arthritis.
    Rheumatol Int. 2022 Jan 5. pii: 10.1007/s00296-021-05080.
    PubMed     Abstract available
    
    
    
100. CHEN X, Hu QY, Wang M, Jia J, et al
     Serum VEGF-C as an evaluation marker of disease activity in adult-onset Still's disease.
     Rheumatol Int. 2022;42:149-157.
     PubMed     Abstract available
     
     
     December 2021
101. FRANKOWSKI M, Swierkot J, Gomulkiewicz M, Korman L, et al
     Usefulness of noninvasive diagnostic procedures for assessment of methotrexate hepatotoxicity in patients with rheumatoid arthritis.
     Rheumatol Int. 2021 Dec 6. pii: 10.1007/s00296-021-05059.
     PubMed     Abstract available
     
     
     
102. BAICUS C
     The stratification of primary Sjogren's syndrome: is it really solving the problem?
     Rheumatol Int. 2021;41:2241.
     PubMed    
     
     
     November 2021
103. BALCHIN C, Tan AL, Wilson OJ, McKenna J, et al
     Participation in physical activity decreased more in people with rheumatoid arthritis than the general population during the COVID-19 lockdown: a cross-sectional study.
     Rheumatol Int. 2021 Nov 30. pii: 10.1007/s00296-021-05054.
     PubMed     Abstract available
     
     
     
104. ROMERA BAURES M, Seoane-Mato D, Alegre-Sancho JJ, Leon L, et al
     Impact of rheumatoid arthritis on sexuality: adaptation and validation of the Qualisex questionnaire for use in Spain.
     Rheumatol Int. 2021 Nov 16. pii: 10.1007/s00296-021-05043.
     PubMed     Abstract available
     
     
     
105. SERBAN A, Mihai A, Dima A, Balaban DV, et al
     The impact of the COVID-19 pandemic on patients with primary Sjogren syndrome.
     Rheumatol Int. 2021;41:1933-1940.
     PubMed     Abstract available
     
     
     
106. DARDER A, Losada Lopez I, Gomez-Bellvert C, Rodriguez A, et al
     Pulmonary nodular lymphoid hyperplasia and Sjogren's syndrome: a case report and literature review.
     Rheumatol Int. 2021;41:2041-2044.
     PubMed     Abstract available
     
     
     
107. PRIORI R, Giardina F, Izzo R, Gattamelata A, et al
     Resilience in women with primary Sjogren's syndrome.
     Rheumatol Int. 2021;41:1987-1994.
     PubMed     Abstract available
     
     
     October 2021
108. DE COCK D, Buckinx E, Pazmino S, Bertrand D, et al
     Belgian rheumatologists' preferences regarding measures of disease activity in patients with rheumatoid arthritis: results from a mixed-methods study.
     Rheumatol Int. 2021 Oct 23. pii: 10.1007/s00296-021-05020.
     PubMed     Abstract available
     
     
     
109. WOLKORTE R, Heesink L, Kip MMA, Koffijberg H, et al
     Monitoring of rheumatoid arthritis: a patient survey on disease insight and possible added value of an innovative inflammation monitoring device.
     Rheumatol Int. 2021 Oct 21. pii: 10.1007/s00296-021-05026.
     PubMed     Abstract available
     
     
     
110. MORALES-ETCHEGARAY I, Garcia-Carrasco M, Munguia-Realpozo P, Mendoza-Pinto C, et al
     Changing trends in rheumatoid arthritis mortality in Mexico, from 1998 to 2017.
     Rheumatol Int. 2021 Oct 5. pii: 10.1007/s00296-021-05013.
     PubMed     Abstract available
     
     
     
111. USKUDAR CANSU D, Uskudar Teke H, Korkmaz C
     Temporal artery biopsy for suspected giant cell arteritis: a retrospective analysis.
     Rheumatol Int. 2021;41:1803-1810.
     PubMed     Abstract available
     
     
     
112. MITTAL GK, Mittal S, Kaur H, Stephen SR, et al
     Anti-Sjogren's-syndrome-related antigen A autoantibodies (Anti-SSA antibody) and meningoencephalitis: Sjogren's syndrome waiting to be unveiled? A case series and review of literature.
     Rheumatol Int. 2021;41:1855-1866.
     PubMed     Abstract available
     
     
     September 2021
113. BELANI PJ, Kavadichanda CG, Negi VS
     Comparison between leflunomide and sulfasalazine based triple therapy in methotrexate refractory rheumatoid arthritis: an open-label, non-inferiority randomized controlled trial.
     Rheumatol Int. 2021 Sep 29. pii: 10.1007/s00296-021-04994.
     PubMed     Abstract available
     
     
     
114. MELIKOGLU MA, Ataman S, Bodur H, Cay HF, et al
     Clinical performance of rheumatoid arthritis impact of disease score: a real-life evidence from the multicenter nationwide registry BioStaR.
     Rheumatol Int. 2021 Sep 24. pii: 10.1007/s00296-021-04992.
     PubMed     Abstract available
     
     
     
115. ALMUTAIRI K, Nossent J, Preen DB, Keen H, et al
     The temporal association between hospital admissions, biological therapy usage and direct health care costs in rheumatoid arthritis patients.
     Rheumatol Int. 2021 Sep 18. pii: 10.1007/s00296-021-04985.
     PubMed     Abstract available
     
     
     
116. NAFFAA ME, Hassan F, Golan-Cohen A, Merzon E, et al
     Factors associated with drug survival on first biologic therapy in patients with rheumatoid arthritis: a population-based cohort study.
     Rheumatol Int. 2021 Sep 16. pii: 10.1007/s00296-021-04989.
     PubMed     Abstract available
     
     
     
117. BARTELS LE, Ammitzboll C, Andersen JB, Vils SR, et al
     Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritis.
     Rheumatol Int. 2021 Sep 2. pii: 10.1007/s00296-021-04972.
     PubMed     Abstract available
     
     
     
118. COLLINS A, Lendrem D, Wason J, Tarn J, et al
     Revisiting the JOQUER trial: stratification of primary Sjogren's syndrome and the clinical and interferon response to hydroxychloroquine.
     Rheumatol Int. 2021;41:1593-1600.
     PubMed     Abstract available
     
     
     
119. GEHIN JE, Klaasen RA, Norli ES, Warren DJ, et al
     Rheumatoid factor and falsely elevated results in commercial immunoassays: data from an early arthritis cohort.
     Rheumatol Int. 2021;41:1657-1665.
     PubMed     Abstract available
     
     
     August 2021
120. GONZALEZ DA, Bianchi ML, Salgado PA, Armada M, et al
     Disease activity and subcutaneous nodules are associated to severe periodontitis in patients with rheumatoid arthritis.
     Rheumatol Int. 2021 Aug 22. pii: 10.1007/s00296-021-04974.
     PubMed     Abstract available
     
     
     
121. ZHAO SS, Nikiphorou E, Young A, Kiely PDW, et al
     Large joints are progressively involved in rheumatoid arthritis irrespective of rheumatoid factor status-results from the early rheumatoid arthritis study.
     Rheumatol Int. 2021 Aug 16. pii: 10.1007/s00296-021-04931.
     PubMed     Abstract available
     
     
     
122. MACIVER A, Hollinger H, Carolan C
     Tele-health interventions to support self-management in adults with rheumatoid arthritis: a systematic review.
     Rheumatol Int. 2021;41:1399-1418.
     PubMed     Abstract available
     
     
     July 2021
123. SOBEJANA M, van den Hoek J, Metsios GS, Kitas GD, et al
     Cardiorespiratory fitness and physical activity in people who have rheumatoid arthritis at an increased risk of cardiovascular disease: a cross-sectional study.
     Rheumatol Int. 2021 Jul 31. pii: 10.1007/s00296-021-04903.
     PubMed     Abstract available
     
     
     
124. ZURA N, Vukorepa M, Jurak I, Peric P, et al
     Decrease in handgrip strength in rheumatoid arthritis (RA): is there a sex-related difference?
     Rheumatol Int. 2021 Jul 28. pii: 10.1007/s00296-021-04959.
     PubMed     Abstract available
     
     
     
125. BARIK RR, Bhatt LK
     Emerging epigenetic targets in rheumatoid arthritis.
     Rheumatol Int. 2021 Jul 26. pii: 10.1007/s00296-021-04951.
     PubMed     Abstract available
     
     
     
126. JOHNSTONE G, Treharne GJ, Fletcher BD, Lamar RSM, et al
     Mental health and quality of life for people with rheumatoid arthritis or ankylosing spondylitis in Aotearoa New Zealand following the COVID-19 national lockdown.
     Rheumatol Int. 2021 Jul 23. pii: 10.1007/s00296-021-04952.
     PubMed     Abstract available
     
     
     
127. MULLER K, Kuipers JG, Weis J, Fischer I, et al
     Self-reported fatigue in patients with rheumatoid arthritis compared to patients with cancer: results from two large-scale studies.
     Rheumatol Int. 2021 Jul 16. pii: 10.1007/s00296-021-04948.
     PubMed     Abstract available
     
     
     
128. HONNE K, Bando M, Mieno MN, Iwamoto M, et al
     Bronchiectasis is as crucial as interstitial lung disease in the severe pneumonia that occurs during treatment with biologic DMARDs in rheumatoid arthritis: a retrospective cohort study in a single facility.
     Rheumatol Int. 2021 Jul 12. pii: 10.1007/s00296-021-04934.
     PubMed     Abstract available
     
     
     
129. NAKAJIMA T, Watanabe R, Hashimoto M, Murata K, et al
     Neutrophil count reduction 1 month after initiating tocilizumab can predict clinical remission within 1 year in rheumatoid arthritis patients.
     Rheumatol Int. 2021 Jul 9. pii: 10.1007/s00296-021-04944.
     PubMed     Abstract available
     
     
     
130. YAGIZ B, Coskun BN, Pehlivan Y, Dalkilic E, et al
     In the era of disease-modifying antirheumatic drugs, how close are we to treating rheumatoid arthritis without the use of glucocorticoids?
     Rheumatol Int. 2021 Jul 5. pii: 10.1007/s00296-021-04939.
     PubMed     Abstract available
     
     
     
131. CHEVALLARD M, Belloli L, Ughi N, Adinolfi A, et al
     Use of telemedicine during the COVID-19 pandemic in patients with inflammatory arthritis: a retrospective study on feasibility and impact on patient-reported outcomes in a real-life setting.
     Rheumatol Int. 2021;41:1253-1261.
     PubMed     Abstract available
     
     
     
132. MULLER R
     Systemic toxicity of chloroquine and hydroxychloroquine: prevalence, mechanisms, risk factors, prognostic and screening possibilities.
     Rheumatol Int. 2021;41:1189-1202.
     PubMed     Abstract available
     
     
     June 2021
133. OULKADI L, Rostom S, Hmamouchi I, El Hassani Sbai S, et al
     Prevalence of latent tuberculosis before biotherapy initiation in rheumatoid arthritis and spondyloarthritis: data from the Moroccan biotherapy registry.
     Rheumatol Int. 2021 Jun 26. pii: 10.1007/s00296-021-04929.
     PubMed     Abstract available
     
     
     
134. GOMEZ-GALICIA DL, Aguilar-Castillo J, Garcia-Garcia C, Moctezuma-Rios JF, et al
     Qualitative validation of audiovisual educational material for use on rheumatoid arthritis patients.
     Rheumatol Int. 2021 Jun 19. pii: 10.1007/s00296-021-04921.
     PubMed     Abstract available
     
     
     
135. TANAKA K, Kimura E, Oryoji K, Mizuki SI, et al
     Hypertension and dyslipidemia are risk factors for herpes zoster in patients with rheumatoid arthritis: a retrospective analysis using a medical information database.
     Rheumatol Int. 2021 Jun 6. pii: 10.1007/s00296-021-04889.
     PubMed     Abstract available
     
     
     
136. SEBASTIAN A, Woytala P, Madej M, Proc K, et al
     Is it possible to not perform salivary gland biopsy in targeted patients according to unstimulated salivary flow results in patients with suspected Sjogren's syndrome?
     Rheumatol Int. 2021;41:1125-1131.
     PubMed     Abstract available
     
     
     
137. WADE SD, Kyttaris VC
     Rituximab-associated hypogammaglobulinemia in autoimmune rheumatic diseases: a single-center retrospective cohort study.
     Rheumatol Int. 2021;41:1115-1124.
     PubMed     Abstract available
     
     
     May 2021
138. FAYET F, Pereira B, Fan A, Rodere M, et al
     Therapeutic education improves rheumatoid arthritis patients' knowledge about methotrexate: a single center retrospective study.
     Rheumatol Int. 2021 May 29. pii: 10.1007/s00296-021-04893.
     PubMed     Abstract available
     
     
     
139. SOYSAL E, Ulutas F, Tepeli E, Kaymaz S, et al
     IL-23R gene polymorphisms in rheumatoid arthritis.
     Rheumatol Int. 2021 May 12. pii: 10.1007/s00296-021-04881.
     PubMed     Abstract available
     
     
     
140. BHATIA A, Kc M, Gupta L
     Increased risk of mental health disorders in patients with RA during the COVID-19 pandemic: a possible surge and solutions.
     Rheumatol Int. 2021;41:843-850.
     PubMed     Abstract available
     
     
     
141. MIGKOS MP, Kaltsonoudis E, Pelechas E, Drossou V, et al
     Use of conventional synthetic and biologic disease-modifying anti-rheumatic drugs in patients with rheumatic diseases contracting COVID-19: a single-center experience.
     Rheumatol Int. 2021;41:903-909.
     PubMed     Abstract available
     
     
     
142. HEGEMAN MC, Schoemaker-Delsing JA, Luttikholt JTM, Vonkeman HE, et al
     Patient perspectives on how to improve education on medication side effects: cross-sectional observational study at a rheumatology clinic in The Netherlands.
     Rheumatol Int. 2021;41:973-979.
     PubMed     Abstract available
     
     
     
143. MANOJ M, Sahoo RR, Singh A, Hazarika K, et al
     Prevalence of hydroxychloroquine retinopathy with long-term use in a cohort of Indian patients with rheumatic diseases.
     Rheumatol Int. 2021;41:929-937.
     PubMed     Abstract available
     
     
     April 2021
144. KAESTNER S, Wolff HJ, Braeuer R, Kaestner P, et al
     Immunoglobulin deficiencies in treated patients suffering from rheumatoid arthritis.
     Rheumatol Int. 2021 Apr 29. pii: 10.1007/s00296-021-04871.
     PubMed     Abstract available
     
     
     
145. MAEDA Y, Hirano T, Ebina K, Hara R, et al
     Comparison of efficacy between anti-IL-6 receptor antibody and other biological disease-modifying antirheumatic drugs in the patients with rheumatoid arthritis who have knee joint involvement: the ANSWER cohort, retrospective study.
     Rheumatol Int. 2021 Apr 26. pii: 10.1007/s00296-021-04862.
     PubMed     Abstract available
     
     
     
146. TONGA E, Williamson E, Srikesavan C, Ozen T, et al
     A hand exercise mobile app for people with rheumatoid arthritis in Turkey: design, development and usability study.
     Rheumatol Int. 2021 Apr 18. pii: 10.1007/s00296-021-04860.
     PubMed     Abstract available
     
     
     
147. LU H, Yao Y, Yang J, Zhang H, et al
     Microbiome-miRNA interactions in the progress from undifferentiated arthritis to rheumatoid arthritis: evidence, hypotheses, and opportunities.
     Rheumatol Int. 2021 Apr 15. pii: 10.1007/s00296-021-04798.
     PubMed     Abstract available
     
     
     
148. CHELLAMUTHU G, Muthu S, Khanna M, Khanna V, et al
     "Platelet-rich plasma holds promise in management of rheumatoid arthritis"-systematic review.
     Rheumatol Int. 2021 Apr 8. pii: 10.1007/s00296-021-04849.
     PubMed     Abstract available
     
     
     
149. ELZORKANY B, Mokbel A, Gamal SM, Hmamouchi I, et al
     Does smoking affect level of seropositivity in RA? A post-HOC global and inter-country analysis of COMORA cohort.
     Rheumatol Int. 2021;41:699-705.
     PubMed     Abstract available
     
     
     
150. DEY M, Zhao SS
     Google search data as a novel adjunct to patient and public involvement in rheumatology research.
     Rheumatol Int. 2021;41:771-779.
     PubMed     Abstract available
     
     
     
151. AKYOL A, Kocyigit BF
     Publication activity in the field of Sjogren's syndrome: a ten-year Web of Science based analysis.
     Rheumatol Int. 2021;41:763-769.
     PubMed     Abstract available
     
     
     March 2021
152. MASLINSKA M, Manczak M, Kwiatkowska B, Ramsperger V, et al
     IgA immunoglobulin isotype of rheumatoid factor in primary Sjogren's syndrome.
     Rheumatol Int. 2021;41:643-649.
     PubMed     Abstract available
     
     
     January 2021
153. ANGELOPOULOU F, Bogdanos D, Dimitroulas T, Sakkas L, et al
     Immune checkpoint inhibitor-induced musculoskeletal manifestations.
     Rheumatol Int. 2021;41:33-42.
     PubMed     Abstract available
     
     
     July 2020
154. ELGHAWY AA, Skopis M, Davis J, Bag-Ozbek A, et al
     Angiostrongyliasis infection masquerading as granulomatosis with polyangiitis: a case-based review.
     Rheumatol Int. 2020;40:1171-1176.
     PubMed     Abstract available
     
     
     
155. LI R, Wan Q, Chen P, Mao S, et al
     Tocilizumab treatment in Felty's syndrome.
     Rheumatol Int. 2020;40:1143-1149.
     PubMed     Abstract available
     
     
     
156. LEE SB, Choi H, Kim MK, Jung SM, et al
     Can antineutrophil cytoplasmic antibody positivity at diagnosis predict the poor outcomes of Sjogren's syndrome?
     Rheumatol Int. 2020;40:1063-1070.
     PubMed     Abstract available
     
     
     May 2020
157. PARK EH, Lee EY, Shin K, Kim HA, et al
     Tocilizumab-induced anaphylaxis in patients with adult-onset Still's disease and systemic juvenile idiopathic arthritis: a case-based review.
     Rheumatol Int. 2020;40:791-798.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Rheumatoid Arthritis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: